Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1233431

	registered interest
	date	10/09/2020
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Coronavirus: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support research into the efficacy of a covid-19 vaccine in older people.
	tabling member constituency	Ayr, Carrick and Cumnock
	tabling member printed	Allan Dorans
	uin	88388
	answer	answer is ministerial correction date of answer 17/09/2020 answer text <p>The University of Oxford / Astra Zeneca Phase 3 trial includes arms that specifically looks at safety and efficacy of the vaccine in those aged between 56 – 69 and over 70. For these groups, researchers are assessing the immune response to the vaccine in people of different ages, to find out if there is variation in how well the immune system responds in older people. Other vaccine developers that the Government are working with may also decide to include specific groups such as these in their trials.</p><p> </p><p>In addition to the work that vaccine developers are undertaking, the Government has funded the NHS Registry, developed by the National Institute for Health Research (NIHR). This national registry is encouraging people who may be disproportionately affected by COVD19, such as older people, older people with underlying health conditions and people from different ethnic groups, to volunteer for clinical trials. This includes supporting the development of communications materials to provide information on taking part in COVID 19 vaccine trials via the NIHR website (Be Part of Research).</p> answering member constituency Derby North answering member printed Amanda Solloway question first answered 17/09/2020 17:54:29 answering member 4372 label Biography information for Amanda Solloway
	tabling member	4740 label Biography information for Allan Dorans

1233433

	registered interest
	date	10/09/2020
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Coronavirus: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support research into understanding the biological mechanisms of long term covid-19 symptoms.
	tabling member constituency	Ayr, Carrick and Cumnock
	tabling member printed	Allan Dorans
	uin	88389
	answer	answer is ministerial correction date of answer 18/09/2020 answer text <p>Understanding the biological mechanisms of COVID-19 and its longer-term impacts is a priority topic in UK Research and Innovation’s (UKRI) research response. In partnership with National Institute for Health Research (NIHR), UKRI has announced an £8.4 million project that will investigate the physical and mental health impacts of hospitalised patients. The Post-HOSPitalisation COVID-19 (PHOSP-COVID) study, led by Professor Chris Brightling from the University of Leicester, aims to recruit 8,000 patients from across the UK. This will make it one of the world’s largest studies into the long-term health consequences of COVID-19. Results from the study will inform the development of new and better measures to treat and rehabilitate patients hospitalised with COVID-19.</p><p>Additional supported work includes a £0.6 million award to Dr James Peters at Imperial College London for the mechanisms underlying the excessive inflammatory response developed in a subset of COVID-19 patients, and a £0.8 million award to Professor John Greenwood Leeds Teaching Hospitals NHS Trust, who will use magnetic resonance imaging to diagnose and understand cardiac injuries in COVID-19 patients. These awards were made through the UKRI-NIHR COVID-19 Rapid Response Rolling Call.</p><p> </p> answering member constituency Derby North answering member printed Amanda Solloway question first answered 18/09/2020 12:21:57 answering member 4372 label Biography information for Amanda Solloway
	tabling member	4740 label Biography information for Allan Dorans

1233434

	registered interest
	date	10/09/2020
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Horizon 2020
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent steps his Department has taken to prepare for the UK potentially not associating to Horizon Europe after the transition period.
	tabling member constituency	Ayr, Carrick and Cumnock
	tabling member printed	Allan Dorans
	uin	88390
	answer	answer is ministerial correction date of answer 17/09/2020 answer text <p>In tandem with our negotiations to associate to EU programmes we, as a responsible government, are developing alternative schemes to support international research and innovation collaboration. If we do not formally associate to Horizon Europe, we will implement ambitious alternatives as quickly as possible from January 2021 and address the funding gap. We will launch an ambitious new Discovery Fund offering sizeable grants over long periods of time to early, mid and late-career researchers, whether already in the UK or coming here from anywhere in the world, to pursue ground-breaking research. We will scale up and enhance prestigious domestic schemes, providing funding to allow UK researchers and innovators to seize opportunities and to allow our institutions to attract and retain international talent and we will make funding available to allow UK partners to participate in European schemes open to third countries.</p> answering member constituency Derby North answering member printed Amanda Solloway question first answered 17/09/2020 17:55:53 answering member 4372 label Biography information for Amanda Solloway
	tabling member	4740 label Biography information for Allan Dorans